Northern Trust
AVDL

Northern Trust’s Avadel Pharmaceuticals AVDL Stock Holding History

Northern Trust’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-797,200
Closed -$17.2M – 4407
2025
Q4 		$17.2M Sell
797,200
-59,641
-7% -$1.16M ﹤0.01% 1772
2025
Q3 		$13.1M Buy
856,841
+17,724
+2% +$231K ﹤0.01% 1954
2025
Q2 		$7.43M Buy
839,117
+199,251
+31% +$1.75M ﹤0.01% 2232
2025
Q1 		$5.01M Sell
639,866
-18,716
-3% -$157K ﹤0.01% 2400
2024
Q4 		$6.92M Buy
658,582
+66,948
+11% +$813K ﹤0.01% 2333
2024
Q3 		$7.76M Buy
+591,634
New +$9.01M ﹤0.01% 2219
2021
Q2 		– Sell
-20,781
Closed -$188K – 4592
2021
Q1 		$188K Sell
20,781
-238
-1% -$1.92K ﹤0.01% 4130
2020
Q4 		$140K Sell
21,019
-581
-3% -$3.63K ﹤0.01% 4046
2020
Q3 		$109K Sell
21,600
-63
-0.3% -$458 ﹤0.01% 3946
2020
Q2 		$175K Buy
21,663
+6,744
+45% +$59.5K ﹤0.01% 3792
2020
Q1 		$118K Sell
14,919
-691
-4% -$5.31K ﹤0.01% 3787
2019
Q4 		$118K Sell
15,610
-50
-0.3% -$264 ﹤0.01% 3904
2019
Q3 		$65K Buy
15,660
+14
+0.1% +$35 ﹤0.01% 4012
2019
Q2 		$45K Sell
15,646
-1,178
-7% -$2.02K ﹤0.01% 4096
2019
Q1 		$24K Sell
16,824
-360
-2% -$814 ﹤0.01% 4114
2018
Q4 		$44K Sell
17,184
-352
-2% -$1.2K ﹤0.01% 4068
2018
Q3 		$77K Buy
17,536
+2,063
+13% +$11.1K ﹤0.01% 4070
2018
Q2 		$95K Buy
15,473
+1,602
+12% +$11.2K ﹤0.01% 4028
2018
Q1 		$101K Sell
13,871
-301
-2% -$2.65K ﹤0.01% 3974
2017
Q4 		$116K Sell
14,172
-534
-4% -$5.01K ﹤0.01% 3941
2017
Q3 		$154K Sell
14,706
-342
-2% -$3.27K ﹤0.01% 3856
2017
Q2 		$166K Sell
15,048
-961
-6% -$9.65K ﹤0.01% 3856
2017
Q1 		$155K Buy
+16,009
New +$160K ﹤0.01% 3859
2015
Q2 		– Sell
-4,050
Closed -$73K – 4240
2015
Q1 		$73K Hold
4,050
– – ﹤0.01% 4102
2014
Q4 		$69K Buy
4,050
+1,975
+95% +$28.2K ﹤0.01% 4050
2014
Q3 		$30K Sell
2,075
-15,233
-88% -$219K ﹤0.01% 4188
2014
Q2 		$260K Buy
+17,308
New +$209K ﹤0.01% 3771

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Northern Trust's AVDL Position: Q1 2026 in Review

Northern Trust sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 797,200 shares — an estimated $17.2M sold.

Northern Trust first reported a position in AVDL in Q2 2014 and held it in 27 quarters. The position peaked at $17.2M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Northern Trust reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Northern Trust sold 797,200 Avadel Pharmaceuticals shares in Q1 2026, an estimated $17.2M.
  • Northern Trust first reported a position in Avadel Pharmaceuticals in Q2 2014 and held it in 27 quarters.
  • Northern Trust's Avadel Pharmaceuticals position peaked at $17.2M in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.